Showing 1 - 4 results of 4 for search 'Michael Z. Liao', query time: 0.04s Refine Results
  1. 1
    Patient, industry, and regulatory perspective on antibody‐drug conjugates dose optimization

    Patient, industry, and regulatory perspective on antibody‐drug conjugates dose optimization by Salaheldin Hamed, Chunze Li, Michael Z. Liao, Lorna Warwick, Zhu Zhou

    Published 2024-03-01
    Get full text
    Article
  2. 2
    Pharmacokinetics of biologics in gastric cancer

    Pharmacokinetics of biologics in gastric cancer by Junyi Li, David C. Turner, Feifei Li, Xi Chen, Michael Z. Liao, Chunze Li

    Published 2023-04-01
    Get full text
    Article
  3. 3
    Ethnic sensitivity assessment: Polatuzumab vedotin pharmacokinetics in Asian and non‐Asian patients with previously untreated diffuse large B‐cell lymphoma in POLARIX

    Ethnic sensitivity assessment: Polatuzumab vedotin pharmacokinetics in Asian and non‐Asian patients with previously untreated diffuse large B‐cell lymphoma in POLARIX by Michael Z. Liao, Rong Deng, Leonid Gibiansky, Tong Lu, Priya Agarwal, Randall Dere, Calvin Lee, Jamie Hirata, Charles Herbaux, Gilles Salles, Chunze Li, Dale Miles

    Published 2023-12-01
    Get full text
    Article
  4. 4
    Population pharmacokinetics and exposure–response analyses of polatuzumab vedotin in patients with previously untreated DLBCL from the POLARIX study

    Population pharmacokinetics and exposure–response analyses of polatuzumab vedotin in patients with previously untreated DLBCL from the POLARIX study by Rong Deng, Leonid Gibiansky, Tong Lu, Christopher R. Flowers, Laurie H. Sehn, Qi Liu, Priya Agarwal, Michael Z. Liao, Randall Dere, Calvin Lee, Gabriel Man, Jamie Hirata, Chunze Li, Dale Miles

    Published 2024-06-01
    Get full text
    Article

Search Tools: